Sponsor Pipeline

Laplace Interventional, Inc Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Disease Areas
4
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-24 NCT06183684
Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR)…		 Enrollment increased: 45 -> 65 participants
2026-07-24 NCT06183684
Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR)…		 Trial sites expanded: 6 -> 10 locations
2026-07-24 NCT06183684
Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR)…		 date change Primary completion pushed: 2025-12 -> 2027-12
2026-07-24 NCT06183684
Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR)…		 date change Completion pushed: 2030-12 -> 2032-12
Active Trials by Phase
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT07171060 Laplace Early Feasibility Study - Canada Tricuspid Regurgitation Recruiting
NCT06183684 Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR)… Tricuspid Regurgitation Recruiting
NCT07687485 Tricuspid Regurgitation Treatment With LAPLACE Transcatheter Tricuspid Valve Replacement… Severe Tricuspid Valve Regurgitation Not Yet Recruiting
Disease Areas
Heart Disease (1)
Get alerts when Laplace Interventional, Inc's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free